Cancer Research UK logo.
SearchDonate
  • Search

A study to help doctors predict who will respond well to paclitaxel chemotherapy for cancer of the ovary (OXO PCR 01)

Overview

Cancer types:

Ovarian cancer

Status:

Closed

Phase:

Phase 0

Details

This study is looking at cancer samples, blood samples and scans to see how and why women with certain types of ovarian cancer do or don’t respond to paclitaxel chemotherapy.

Recruitment start: 26 November 2012

Recruitment end: 28 February 2016

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Ahmed Ahmed

Supported by

Biomedical Research Council (BRC)

Experimental Cancer Medicine Centre (ECMC)

Medical Research Council (MRC)

National Institute for Health Research (NIHR)

Oncology Clinical Trials Office (OCTO)

University of Oxford

Last reviewed: 28 Feb 2016

CRUK internal database number: 9958

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.